Of these 13 cancers, ANKHD1 is upregulated in specific subsets of glioma, renal cell carcinoma and leukaemia, which validates previous evidence that ANKHD1 is overexpressed in those cancer types [13,16,17,33]. Here, ANKHD1 is linked to leukemia.